Abstract

The flavonoid rutin presents several pharmacological effects, despite this, its application in the pharmaceutical industry can be significantly limited by its low bioavailability. The development of lipophilic derivatives by esterification of hydroxyl groups with fatty acid chains may be an effective strategy to change their physicochemical properties. This work aims to use high-speed countercurrent chromatography (HSCCC) to isolate rutin esters produced by esterification reactions catalyzed by the immobilized lipase from Candida antarctica (Novozyme 435®). The lipase-catalyzed synthesis of rutin esters (R3-R18:2) in 2-methyl-2-butanol exhibited conversions that ranged from 16 to 40% and highest conversion for short chain fatty acids (R4-R12). After initial partitioning tests of the reaction mixture in different solvent proportions followed by thin layer chromatography (TLC) analysis, the biphasic solvent systems consisting in HEMWat (hexane/ethyl acetate/methanol/water) in different proportions were chosen to separate rutin esters. These esters were separated for the first time to the reaction mixture via HSCCC. This technique proved to be more advantageous than the traditionally one since it allowed quick isolation and high purity (≥ 90%) of the products. It also permitted a substrate recovery for reuse in other enzymatic reactions. Furthermore, the results add valuable information, specially concerning the structures elucidation of different rutin esters not previously described.

Highlights

  • Flavonoids are an important natural product group widely distributed in the plant kingdom.[1]

  • This work aims to develop and apply a method using high-speed countercurrent chromatography (HSCCC) to isolate rutin esters produced by reactions catalyzed by immobilized lipase from Candida antarctica (Novozyme 435®)

  • The synthesis of rutin esters were performed in 2-methylbutan-2-ol

Read more

Summary

Introduction

Flavonoids are an important natural product group widely distributed in the plant kingdom.[1]. Rutin has already been associated with various pharmacological potentials including antioxidant, antimicrobial, anti-inflammatory, anticancer, antidiabetic, antiallergic and neuroprotective activities.[1,3] Despite this, the efficacy of rutin can be significantly limited by its low bioavailability.[1]. The development of lipophilic derivatives of rutin through the esterification of hydroxyl groups with fatty acid chains can be an effective strategy to modify their physicochemical properties and, likely, to favor their bioavailability. This structural modification can be a strategy to improve the pharmacological activity of the generated ester compared to the original compound.[4,5]

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call